Please assess the completion status of the following clinical trial:

Trial Title: HW006 LATERAL Thoracotomy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Must be ≥19 years of age at time of informed consent to participate in the Intermacs® registry.~2. Subject receives a HeartWare HVAD (The device should be the subject's first VAD implant).~3. Subject signed an Intermacs® informed consent if required by local IRB policy.~4. Subject signed a HeartWare informed consent.~Exclusion Criteria:~1. Subject is incarcerated (prisoner).~2. Subject did not sign the informed consent at sites where waiver of consent was not granted.~3. Body Surface Area (BSA) \< 1.2 m\^2.~4. Prior cardiac transplant or cardiomyoplasty.~5. Subject is receiving a BiVAD.~6. Subject is receiving the device as an RVAD.~7. Subject data is generated from non- Intermacs® centers.~8. Pediatric subjects (\< 19 years of age).~9. Subjects who receive a temporary LVAD~10. Subjects whose device strategy is listed as Destination Therapy at the time of implant.~11. Severe Right Heart failure~12. Aortic insufficiency or mechanical aortic valve.~13. Planned concomitant procedure (e.g.valve repair or replacement, CABG, septal defect repair).~14. Known LV Thrombus.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- HeartWare HVAD via Thoracotomy (Type: EXPERIMENTAL): HeartWare HVAD implanted via thoracotomy

Based on this trial design, predict the completion outcome and termination type (if applicable).